Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean L Koff

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Biologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar Lonial
Cancer|May 3, 2017
Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?Jean L Koff, Christopher R Flowers
Cancer|January 10, 2019
Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?Jean L Koff, Edmund K Waller
Expert Review of Hematology|April 22, 2016
B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune diseaseJean L Koff, Christopher R Flowers
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2017
Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare CohortJean L Koff, Ashish Rai, Christopher R Flowers
Expert Opinion on Investigational Drugs|June 2, 2018
Targeting the B cell receptor pathway in non-Hodgkin lymphomaKelly Valla, Christopher R Flowers, Jean L Koff
International Journal of Molecular Sciences|January 31, 2015
A time to kill: targeting apoptosis in cancerJean L Koff, Sampath Ramachandiran, Leon Bernal-Mizrachi
Cancer|June 26, 2015
Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphomaJessica N Williams, Jean L Koff, Christopher R Flowers
Blood Cancer Discovery|June 24, 2026
Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic LogicLaura K Hilton, Christopher R Flowers, Jean L Koff
Oncology (Williston Park, N.Y.)|November 7, 2014
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategiesLoretta J Nastoupil, Jean L Koff, Christopher R Flowers
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Biologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar Lonial
Cancer|May 3, 2017
Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?Jean L Koff, Christopher R Flowers
Cancer|January 10, 2019
Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?Jean L Koff, Edmund K Waller
Expert Review of Hematology|April 22, 2016
B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune diseaseJean L Koff, Christopher R Flowers
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2017
Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare CohortJean L Koff, Ashish Rai, Christopher R Flowers
Expert Opinion on Investigational Drugs|June 2, 2018
Targeting the B cell receptor pathway in non-Hodgkin lymphomaKelly Valla, Christopher R Flowers, Jean L Koff
International Journal of Molecular Sciences|January 31, 2015
A time to kill: targeting apoptosis in cancerJean L Koff, Sampath Ramachandiran, Leon Bernal-Mizrachi
Cancer|June 26, 2015
Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphomaJessica N Williams, Jean L Koff, Christopher R Flowers
Blood Cancer Discovery|June 24, 2026
Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic LogicLaura K Hilton, Christopher R Flowers, Jean L Koff
Oncology (Williston Park, N.Y.)|November 7, 2014
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategiesLoretta J Nastoupil, Jean L Koff, Christopher R Flowers
Pageof 7